Comment on: Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis. Reply

被引：0
|
作者：
Wang, Jinghua [1 ]
Kong, Xiufang [1 ]
Jin, Xuejuan [2 ]
Jiang, Lindi [1 ,3 ,4 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Dept Rheumatol, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai, Peoples R China
[3] Fudan Univ, Ctr Clin Epidemiol & Evidence Based Med, Shanghai, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Rheumatol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
来源：
RHEUMATOLOGY | 2024年 / 63卷 / 09期
关键词：
D O I：
10.1093/rheumatology/keae015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e276 / e277
页数：2
相关论文
共 50 条
  • [1] Comment on: Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis
    Misra, Durga Prasanna
    RHEUMATOLOGY, 2024, 63 (05) : e156 - e157
  • [2] Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis: an open-label study
    Wang, Jinghua
    Kong, Xiufang
    Ma, Lili
    Ding, Zhenqi
    Chen, Huiyong
    Chen, Rongyi
    Jin, Xuejuan
    Chen, Caizhong
    Lin, Jiang
    Jiang, Lindi
    RHEUMATOLOGY, 2023, : 1359 - 1367
  • [3] TREATMENT EFFICACY AND SAFETY OF ADALIMUMAB VERSUS TOCILIZUMAB COMBINED WITH METHOTREXATE AND GLUCOCORTICOIDS IN PATIENTS WITH ACTIVE AND SEVERE TAKAYASU ARTERITIS: A RANDOMIZED, OPEN-LABEL, HEAD-TOHEAD STUDY
    Kong, X.
    Wang, J.
    Ma, L.
    Chen, H.
    Ding, Z.
    Jin, X.
    Jiang, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 636 - 637
  • [4] Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis
    Lee, Young Ho
    Song, Gwan Gyu
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (01)
  • [5] EFFICACY AND SAFETY OF TOCILIZUMAB IN EIGHT PATIENTS WITH TAKAYASU ARTERITIS
    Palmou-Fontana, N.
    Loricera, J.
    Blanco, R.
    Hernandez, J. L.
    Castaneda, S.
    Humbria, A.
    Ortego, N.
    Bravo, B.
    Freire, M.
    Melchor, S.
    Minguez, M.
    Salvatierra, J.
    Gonzalez-Vela, C.
    Calvo-Rio, V.
    Pina, T.
    Gonzalez-Gay, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 301 - 301
  • [6] SAFETY AND EFFICACY OF SHORT-TERM TREATMENT WITH TOCILIZUMAB IN PATIENTS WITH REFRACTORY TAKAYASU ARTERITIS
    Novikov, P.
    Smitienko, I.
    Elonakov, A.
    Koilubaeva, G.
    Moiseev, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 302 - 302
  • [7] Response to: 'Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis' by Lee and Song
    Nakaoka, Yoshikazu
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (01)
  • [8] The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis
    Zhou, J.
    Chen, Z.
    Li, J.
    Yang, Y.
    Zhao, J.
    Chen, H.
    Liu, M.
    Sun, F.
    Li, M.
    Tian, X.
    Zeng, X.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (01) : S171 - S175
  • [9] THE EFFICACY OF TOCILIZUMAB ON THE TREATMENT OF TAKAYASU ARTERITIS IN CHINESE CHILDREN
    Wang, C.
    Song, H.
    Yu, Z.
    Quan, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1794 - 1794
  • [10] Tocilizumab for the Treatment of Patients With Refractory Takayasu Arteritis
    Nakaoka, Yoshikazu
    Higuchi, Kaori
    Arita, Yoh
    Otsuki, Michio
    Yamamoto, Kaori
    Hashimoto-Kataka, Takahiro
    Yasui, Taku
    Ikeoka, Kuniyasu
    Ohtani, Tomohito
    Sakata, Yasushi
    Shima, Yoshihito
    Kumanogoh, Atsushi
    Yamauchi-Takihara, Keiko
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    Komuro, Issei
    INTERNATIONAL HEART JOURNAL, 2013, 54 (06) : 405 - 411
12345